Viatris Inc. (VTRS)
Bid | 7.5 |
Market Cap | 8.96B |
Revenue (ttm) | 14.73B |
Net Income (ttm) | -634.2M |
EPS (ttm) | -0.53 |
PE Ratio (ttm) | -14.17 |
Forward PE | 4.24 |
Analyst | Hold |
Ask | 7.52 |
Volume | 4,794,784 |
Avg. Volume (20D) | 14,906,677.4 |
Open | 7.67 |
Previous Close | 7.54 |
Day's Range | 7.42 - 7.68 |
52-Week Range | 6.85 - 13.55 |
Beta | 0.91 |
About VTRS
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, end...
Analyst Forecast
According to 4 analyst ratings, the average rating for VTRS stock is "Hold." The 12-month stock price forecast is $10, which is an increase of 33.16% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

21 hours ago · accessnewswire.com
June 3, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTRSNEW YORK, NY / ACCESS Newswire / April 13, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, f...